On the last Conference Call Eric mentioned that it was Mr. Johnson who was driving Imclones partnering outside the normal cancer settings. I believe he was referring to autoimmune and opthamology fields.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.